Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
15,247
datasets available to search
ShareScore release 0.9.0
Dataset results
15,247 results for “Breast cancer;”
S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo
ClinicalTrials.gov study NCT00382018. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Perioperative CBT on Chronic Persistent Postsurgical Pain Among Breast Cancer Patients
ClinicalTrials.gov study NCT04924010. IPD Sharing: YES. Countries: 1. Publications: 21.
Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
ClinicalTrials.gov study NCT00003782. IPD Sharing: Not stated. Countries: 2. Publications: 3.
A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer
ClinicalTrials.gov study NCT00632541. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Metabolomic Profiling of Erector Spinae Plane Block* for Breast Cancer Surgery
ClinicalTrials.gov study NCT04689945. IPD Sharing: YES. Countries: 1. Publications: 10.
Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer
ClinicalTrials.gov study NCT00093795. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread
ClinicalTrials.gov study NCT03659136. IPD Sharing: NO. Countries: 11. Publications: 2.
BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer
ClinicalTrials.gov study NCT01870505. IPD Sharing: Not stated. Countries: 1. Publications: 1.
NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer
ClinicalTrials.gov study NCT01931163. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
ClinicalTrials.gov study NCT00408408. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases
ClinicalTrials.gov study NCT01421017. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer
ClinicalTrials.gov study NCT01724866. IPD Sharing: NO. Countries: 6. Publications: 1.
Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients With Implant Reconstructions
ClinicalTrials.gov study NCT02086578. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
ClinicalTrials.gov study NCT00338286. IPD Sharing: Not stated. Countries: 21. Publications: 1.
Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer
ClinicalTrials.gov study NCT01234337. IPD Sharing: Not stated. Countries: 23. Publications: 2.
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer
ClinicalTrials.gov study NCT02040857. IPD Sharing: NO. Countries: 1. Publications: 1.
Imaging Performance Assessment of 89Zi-girentuximab (89Zr-TLX250) PET in Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04758780. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
ClinicalTrials.gov study NCT00950300. IPD Sharing: Not stated. Countries: 26. Publications: 2.
A Phase III Trial For Patients With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00191152. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis
ClinicalTrials.gov study NCT00566618. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.